pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
ASTRAZENECA · news · pharmadog
← back to ASTRAZENECA
News mentioning ASTRAZENECA
363
stories
22d
After a brief storm of political headwinds, mRNA is back with strong momentum
biospace
23d
STAT+: Breast cancer pill from AstraZeneca misses mark in pivotal trial
stat
24d
STAT+: Up and down the ladder: The latest comings and goings
stat
24d
Cullinan, Taiho showcase 6-month survival benefit in phase 3 trial for advanced lung cancer
fiercebiotech
24d
Owkin, Servier ink oncology R&D deal to guide discovery and trial design
fiercebiotech
24d
STAT+: Pharmalittle: We’re reading about anxious Novartis investors, patent expirations for biologics, and more
stat
24d
Karyopharm pushes off debt payment; Amgen eyes broader Imdelltra use
biopharma dive
24d
BioNTech sets survival standard in hard-to-treat cancer ahead of pivotal readout
fiercebiotech
25d
In first interview as FDA oncology chief, Angelo de Claro vows to ‘continue the innovation’ behind OCE legacy
fiercebiotech
25d
STAT+: The gifts from pharma companies that keep on giving
stat
25d
STAT+: Pharmalittle: We’re reading about a Novartis investor seeking a shake-up, a Gilead setback, and more
stat
25d
STAT+: Cancer medicines remain in short supply across the U.S., survey finds
stat
25d
Trump officials say AI will help save rural health care. Some leaders in the field don’t believe it
stat
26d
STAT+: U.K. unveils recommendations for regulating AI in medicine
stat
26d
Coroner releases details of infants who died amid growing Pennsylvania measles outbreak
stat
26d
STAT+: Orexin discoverers awarded prestigious Lasker award
stat
26d
STAT+: Pharmalittle: We’re reading about an AstraZeneca COPD win, the FDA filling key jobs, and more
stat
26d
A new immuno-oncology play raises $225M for a next-generation drug
biopharma dive
26d
STAT+: Leukemia drug data suggested a different way to treat diabetes. A new biotech will test that idea
stat
27d
Beeline flies into phase 3 as oral lupus drug soars past placebo
fiercebiotech
27d
Beyond China: Five other overseas destinations for biopharma dollars
biospace
27d
Solstice rises with $225M series A to advance next-gen CTLA-4 immunotherapy into phase 2
fiercebiotech
27d
STAT+: FDA names acting heads of drug and vaccine centers to permanent roles
stat
27d
Roivant surges on ‘exceptional’ results; Bristol Myers touts first-of-its-kind CAR-T therapy
biopharma dive
27d
Sanofi spells out asthma data, AstraZeneca details COPD win at #ERS26
endpoints
27d
STAT+: UnitedHealth’s Democrat investment, and surprise billing bloat debate
stat
27d
Novo shutters 2 more heart disease studies, indicating IL-6 is ‘invalid target’
biospace
27d
STAT+: Health care features prominently in Democrats’ agenda
stat
27d
STAT+: Oura files to goes public, reported $1.2B in earnings
stat
27d
STAT+: FDA approves AstraZeneca breast cancer drug
stat
← prev
page 3 of 13
next →
